All content

Search filter terms
Filter by category
Filter by type
Filter by tag
Filter by user
Filter by licence
Results per page:
Sort by:
Showing 55 results. Use the filters on the left and the search box below to refine the results.
Category: Blob Type: Adobe PDF User: Drkrishnasarmapathy Licence: by-sa
Uploader

Blob Industrial process for OXICONAZOLE Dr Krishnasarma P...

Created: 2012-07-24 11:38:44 | Last updated: 2013-06-21 09:49:15

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Industrial process for OXICONAZOLE Dr Krishnasarma PathyOxiconazole inhibits ergosterol biosynthesis, which is required forcytoplasmic membrane integrity of fungi. It acts to destabilize the fungal cyctochromeP450 51 enzyme (also known as Lanosterol 14-alpha demethylase). This is vital in thecell membrance structure of the fungus. Its inhibition leads to cell lysis. Oxiconazole hasalso been shown in inhibit DNA synthesis and suppress intracellular concentrations ofATP. Like other imidazole an...

File type: Adobe PDF

Comments: 0 | Viewed: 54 times | Downloaded: 103 times

Tags:

Uploader

Blob Chronic Hepatitis (Chc), Viral Polymerase Nucleotide...

Created: 2019-10-12 11:22:31

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Sofosbuvir is a viral polymerase nucleotide inhibitor that was approved in December2013 by the United States Food and Drug Administration (FDA), and in January 2014by the European Medicines Agency for the treatment of HCV infection [1]. The WHOGuidelines for the screening, care and treatment of persons with hepatitis C infectionrecommend sofosbuvir in combination with ribavirin in genotypes 1, 2, 3 and 4 HCVinfection, either with or without pegylated interferon (depending on the HCV genotype)...

File type: Adobe PDF

Comments: 0 | Viewed: 0 times | Downloaded: 0 times

This File has no tags!

Uploader

Blob Bempedoic Acid a Small Molecule Drug Process and Syn...

Created: 2019-07-23 07:04:13

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Low Density Lipoprotein Cholesterol AbstractBempedoic acid (ETC-1002), a small molecule drug, promotes low density lipoprotein (LDL) receptor mediated clearanceof LDL-cholesterol (LDL-C) by inhibition of adenosine triphosphate citrate lyase (ACL), a mechanism complementary to thoseof existing lipid-modifying therapies. Bempedoic acid is a pro-drug activated specifically within the liver where it inhibits ACL,a regulatory checkpoint within the cholesterol biosynthesis pathway. By inhibiti...

File type: Adobe PDF

Comments: 0 | Viewed: 3 times | Downloaded: 0 times

This File has no tags!

Uploader

Blob Crystallization and Polymorphism-Scalable Process fo...

Created: 2018-12-04 11:45:47

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Crystallization and Polymorphism-Scalable Process for Celecoxib and It’s Polymorph From-3

File type: Adobe PDF

Comments: 0 | Viewed: 10 times | Downloaded: 0 times

This File has no tags!

Uploader

Blob Citation: Krishnasarma P, MS Chakravarthy. Crystalli...

Created: 2018-12-04 11:43:44

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Citation: Krishnasarma P, MS Chakravarthy. Crystallization and Polymorphism-Scalable Process for Celecoxib and It’s Polymorph From-3(Non- Steroidal Anti-Inflammatory Drug (NSAID). LOJ Med Sci 2(2)-2018. LOJMS.MS.ID.000134. 125Review ArticleCrystallization and Polymorphism-Scalable Process forCelecoxib and It’s Polymorph From-3 (Non- SteroidalAnti-Inflammatory Drug (NSAID) 

File type: Adobe PDF

Comments: 0 | Viewed: 14 times | Downloaded: 2 times

This File has no tags!

Uploader

Blob Cefpodoxime Proxetil and its By-Products: A Comparat...

Created: 2018-08-31 07:40:48

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Cefpodoxime Proxetil and its By-Products: A Comparative Study as Per EP-7 Krishnasarma pathy*LOJ Med Sci 

File type: Adobe PDF

Comments: 0 | Viewed: 1 time | Downloaded: 0 times

Tags:

Uploader

Blob Biomedical Journal of Scientific & Technical Research.

Created: 2018-08-31 06:24:53

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Considerations for Successful Scale-Up to Tox Batches and Phase-Api (Bulk Drug substance)[*]       Krishnasarma pathy* DOI : 10.26717/BJSTR.2018.08.001662Biomedical Journal of Scientific & Technical Research.

File type: Adobe PDF

Comments: 0 | Viewed: 1 time | Downloaded: 0 times

This File has no tags!

Uploader

Blob Biomedical Journal of Scientific & Technical Researc...

Created: 2018-08-31 06:23:50

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Considerations for Successful Scale-Up to Tox Batches and Phase-Api (Bulk Drug substance)[*]       Krishnasarma pathy* DOI : 10.26717/BJSTR.2018.08.001662Biomedical Journal of Scientific & Technical Research.

File type: Adobe PDF

Comments: 0 | Viewed: 0 times | Downloaded: 0 times

This File has no tags!

Uploader

Blob Case History-The Control of Impurities-A Critical Is...

Created: 2018-08-01 05:40:18

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Case History-The Control of Impurities-A CriticalIssue to The Active Pharmaceutical Ingredient 

File type: Adobe PDF

Comments: 0 | Viewed: 0 times | Downloaded: 0 times

Tags:

Uploader

Blob Case History-The Control of Impurities-A Critical Is...

Created: 2018-08-01 05:35:55

Credits: User Drkrishnasarmapathy

License: Creative Commons Attribution-Share Alike 3.0 Unported License

Case History-The Control of Impurities-A CriticalIssue to The Active Pharmaceutical Ingredient 

File type: Adobe PDF

Comments: 0 | Viewed: 0 times | Downloaded: 0 times

Tags:

Results per page:
Sort by: